Summary
- Current Price
- As of today, IMNM price is $21.04, up +0.43% on
- Current Price All-Time High
- IMNM price is currently -67.01% below its historical high of $63.78 set on
- Market Cap
- IMNM current market cap is $2B, up +190.08% over the past 365 days
- PE Ratio
- IMNM PE ratio is unknown
- Revenue
- IMNM current annual revenue is $9.04M, down -35.50% year-over-year
- Next Earnings
- The next earnings release for IMNM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Immunome, Inc. |
| Ticker | NASDAQ: IMNM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | immunome.com |
| Employees | 131 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $21.04 | |
| Price, 1D Change | +0.43% | |
| $2B | ||
| - | ||
| - | ||
| 1.42 | ||
| $9M | ||
| Revenue, 1Y Change | -35.50% | |
| -$5.00 | ||
| EPS, 1Y Change | +7.18% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$5.00 | ||
| EPS Estimate | -$2.21 | |
| EPS Est. Change | +55.79% | |
| $9.04M | ||
| Revenue Estimate | $7.70M | |
| Revenue Est. Change | -14.80% | |
| Current Price | $21.04 | |
| Price Target | - | $36.00 |
| Price Tgt. Change | - | +71.10% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.15 | -$5.00 | -20.39% | |
| -$2.21 | N/A | +55.79% | |
| -$2.37 | N/A | +52.55% | |
| -$2.11 | N/A | +57.69% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.41M | $9.04M | -3.88% | |
| $7.70M | N/A | -14.80% | |
| $4.44M | N/A | -50.91% | |
| $85.85M | N/A | +849.57% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $21.04 | |
| $15.09 | ||
| SMA 200 vs Price | -28.30% | |
| $22.74 | ||
| SMA 50 vs Price | +8.06% | |
| 1.42 | ||
| $1.30 | ||
| 41.23 | ||
| 49.15% | ||
| 76.96% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $9.04M | ||
| -$5.00 | ||
| $6.94M | ||
| 76.75% | ||
| -$153.46M | ||
| -1,697.33% | ||
| -$292.96M | ||
| -3,240.38% | ||
| -$151.35M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 4.08 | ||
| 4.08 | ||
| - | ||
| - | ||
| 19.34 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 334.46 | ||
| 3.66 | ||
| -7.92 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $181.17M | ||
| $143.35M | ||
| $240.24M | ||
| $221.34M | ||
| $59.08M | ||
| $54.31M | ||
| $4.83M | ||
| $63.00K | ||
| $14.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $162.50M | ||
| $162.50M | ||
| $2.10M | ||
| $32.96M | ||
| $2.10M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$110.79M | ||
| -$85.06M | ||
| $240.53M | ||
| $7.17M | ||
| -$164.30M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Stephens & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | ||
| Wedbush | → | |
| Lake Street | → | |
| Guggenheim | → | |
| Evercore ISI Group | → | |
| Truist Securities | ||
| Stephens & Co. | → | |
| Goldman Sachs |
Analyst sentiment
Institutional ownership
Screeners with IMNM
FAQ
What is the ticker symbol for Immunome, Inc.?
The ticker symbol for Immunome, Inc. is NASDAQ:IMNM
Does Immunome, Inc. pay dividends?
No, Immunome, Inc. does not pay dividends
What sector is Immunome, Inc. in?
Immunome, Inc. is in the Healthcare sector
What industry is Immunome, Inc. in?
Immunome, Inc. is in the Biotechnology industry
What country is Immunome, Inc. based in?
Immunome, Inc. is headquartered in United States
When did Immunome, Inc. go public?
Immunome, Inc. initial public offering (IPO) was on October 2, 2020
Is Immunome, Inc. in the S&P 500?
No, Immunome, Inc. is not included in the S&P 500 index
Is Immunome, Inc. in the NASDAQ 100?
No, Immunome, Inc. is not included in the NASDAQ 100 index
Is Immunome, Inc. in the Dow Jones?
No, Immunome, Inc. is not included in the Dow Jones index
When was Immunome, Inc. last earnings report?
Immunome, Inc.'s most recent earnings report was on March 3, 2026
When does Immunome, Inc. report earnings?
The next expected earnings date for Immunome, Inc. is May 12, 2026
Data Sources & References
- IMNM Official Website immunome.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1472012/000119312526088172/0001193125-26-088172-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1472012/000155837025003302/0001558370-25-003302-index.htm
- IMNM Profile on Yahoo Finance finance.yahoo.com/quote/IMNM
- IMNM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imnm